OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

CUSIP: 68277Q105

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 6 signals
Share change
+105,869
SEC-reported price per share
$4.30
Number of holders
46
Value change
-$1,567,896
Number of buys
18
Number of sells
20
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
40,703,345

Security key

68277Q105

Report period

Q1 2025

Institutions

46

Top holders

10

Ownership snapshot

Top reported holders of OKUR - OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Deep Track Capital, LP
Disclosed value leader
Cormorant Asset Managemen...
Comparable rows
15/15
Latest evidence
16 Jan 2025
13F 13D/G Lead comparable stake: 4.1% 13D/G row: Deep Track Capital, LP Showing 1-6 of 15 holder rows.

Quick read

Deep Track Capital, LP leads the comparable SEC ownership view at 4.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Deep Track Capital, LP's linked filing trail.
Comparable ownership Top 5
Deep Track Capital, LP 4.1%
Invest A/s Lundbeckfond 1.6%
RiverVest Venture Fund III, L.P. 1.6%
Cormorant Asset Management, LP 4.5%
ACORN CAPITAL ADVISORS, LLC 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Deep Track Capital, LP
13F 13D/G
Company
4.1%
from 13D/G
$4,506,305
523,989 shares
31 Dec 2024
Invest A/s Lundbeckfond
13D/G
Lundbeckfond Invest A/S
1.6%
$515,930
203,122 shares
$0 31 Dec 2024
RiverVest Venture Fund III, L.P.
13D/G
John P. McKearn, Ph.D.
1.6%
$333,517
196,198 shares
$0 16 Jan 2025
Cormorant Asset Management, LP
13F
Company
13F
4.5%
$15,804,555
1,837,739 shares
31 Dec 2024
ACORN CAPITAL ADVISORS, LLC
13F
Company
13F
3.5%
$10,247,562
1,439,674 shares
31 Dec 2024
CITADEL ADVISORS LLC
13F
Company
13F
2.6%
$8,782,081
1,074,314 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
46
Shares
11,945,383
Rows available
46
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2026 Across Filers

Q1 2026 holders
51
Q1 2025 holders
46
Holder diff
-5
Investor Q1 2026 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2026 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .